Friday, November 28, 2014 6:48:08 PM
Scott has explained this ... nothing has been hidden or covered up.
From the letter to share holders
Q: Why the increase in the Outstanding Shares (O/S) and Reserve?
(This is, the #1 question I have been asked most recently!)
A: The increase in the O/S is twofold. (1) A few of the Convertible Promissory Notes entered into by the Company in early 2014 (and before) became due and/or presented conversions in Fiscal 2015 Q1. These Notes were allowed to convert out (we have no choice on Notes past their Maturity Date) to preserve operating capital during the hard launch of VitaminFIZZ on both coasts, especially once the launch was determined to be an “unprecedented success” by industry giants. (2) The opportunity to acquire Avanzar was literally a “once in a business plan” opportunity. We needed additional capital to complete this acquisition. The Avanzar acquisition will add an estimated $450,000 per month to Minerco’s FY 2015 top line revenue based on the deal structure. The long term financial and operational gains of this strategic acquisition / integration far outweigh any short term concerns.
Now to verify this here is conversions from last Q that were due and most were from before 2014
On September 3, 2014, we issued 10,000,000 common shares pursuant to a consulting agreement.
On September 3, 2014, we issued 21,666,666 common shares in one (1) transaction upon conversion of a convertible promissory note dated March 3, 2014. These shares of common stock were issued in reliance on Section 3(a)(9) of the Act.
On September 4, 2014, the Company issued 12,000,000 common shares pursuant to a consulting agreement.
On September 4, 2014, the Company issued 8,000,000 common shares pursuant to a consulting agreement.
On September 9, 2014, the Company issued 50,000,000 common shares in one (1) transaction upon conversion of a convertible promissory note dated July 23, 2012. These shares of common stock were issued in reliance on Section 3(a)(9) of the Act.
On September 11, 2014, the Company issued 25,000,000 common shares in one (1) transaction upon conversion of a convertible promissory note dated July 23, 2012. These shares of common stock were issued in reliance on Section 3(a)(9) of the Act.
On September 12, 2014, the Company issued 26,055,560 common shares in one (1) transaction upon conversion of a convertible promissory note dated November 19, 2013. These shares of common stock were issued in reliance on Section 3(a)(9) of the Act.
On September 16, 2014, the Company issued 500,000 common shares under its Key Employee and Distributor Incentive Plan. The shares were issued in reliance upon Section 4(a)(2) of the Act.
On September 16, 2014, the Company issued 500,000 common shares under its Key Employee and Distributor Incentive Plan. The shares were issued in reliance upon Section 4(a)(2) of the Act.
On September 30, 2014, the Company issued 50,000,000 common shares in one (1) transaction upon conversion of a convertible promissory note dated July 23, 2012. These shares of common stock were issued in reliance on Section 3(a)(9) of the Act.
On October 9, 2014, the Company issued 25,000,000 common shares in one (1) transaction upon conversion of a convertible promissory note dated July 23, 2012. These shares of common stock were issued in reliance on Section 3(a)(9) of the Act.
On October 10, 2014, the Company issued 68,632,000 common shares in one (1) transaction upon conversion of a convertible promissory note dated July 23, 2012. These shares of common stock were issued in reliance on Section 3(a)(9) of the Act.
On October 16, 2014, we issued 500,000 common shares pursuant to a consulting agreement. The shares were issued in reliance upon Section 4(a)(2) of the Act.
On October 21, 2014, the Company issued 2,005, 269 common shares in one (1) transaction upon conversion of a convertible promissory note dated March 31, 2014. These shares of common stock were issued in reliance on Section 3(a)(9) of the Act.
On October 27, 2014, the Company issued 10,237,980 common shares in one (1) transaction upon conversion of a convertible promissory note dated March 31, 2014. These shares of common stock were issued in reliance on Section 3(a)(9) of the Act.
On October 29, 2014, the Company issued 25,000,000 common shares in one (1) transaction upon conversion of a convertible promissory note dated July 23, 2012. These shares of common stock were issued in reliance on Section 3(a)(9) of the Act.
The shorters hopped on this because they new all the conversions were going to take it down ... so lets short it ... that time is almost over
2.) Between April 30, 2014 and July 31, 2014, we reduced our derivative liability from $5,291,245 (on 4/30/14) to $650,135 (as of 7/31/14). That’s an over 85% REDUCTION in derivative liability. Expect more reductions as we continue to execute our business model.
Do some reading on MINE over the last 2 years ... its not the normal pinky ... that's what makes since :)
http://www.minercoresources.com/news.php?p=99
http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001451514&type=8-k&dateb=&owner=exclude&count=40
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM